Oasmia Pharmaceutical AB Revenue From Royalties
Oasmia Pharmaceutical AB reported Revenue From Royalties of SEK 2.38 million for the 12-month period ending 2018-04-30, per its 20-F filed 2018-09-14.
Discontinued › Income Statement › Other Income
ifrs-full:RevenueFromRoyalties · last filed 2018-09-14
| Period end | Revenue From Royalties 12 month |
|---|---|
| 2018-04-30 | 2.38M SEK 20-F · filed 2018-09-14 |
| 2017-04-30 | 0.00 SEK 20-F · filed 2018-09-14 |
| 2016-04-30 | 4.87M SEK 20-F · filed 2018-09-14 |